Vantage Consulting Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,655	Closed	-$235K	–	26
2024 Q2	$235K	Buy	5,655 +1,236	+28%	+$55.3K	0.17%	128
2024 Q1	$240K	Sell	4,419 -233	-5%	-$11.9K	0.15%	140
2023 Q4	$239K	Buy	4,652 +844	+22%	+$44.3K	0.16%	146
2023 Q3	$221K	Buy	3,808 +258	+7%	+$15.8K	0.15%	158
2023 Q2	$227K	Sell	3,550 -98	-3%	-$6.57K	0.13%	172
2023 Q1	$253K	Buy	3,648 +576	+19%	+$40.6K	0.14%	148
2022 Q4	$221K	Sell	3,072 -590	-16%	-$44.5K	0.13%	169
2022 Q3	$260K	Buy	3,662 +454	+14%	+$32.9K	0.15%	100
2022 Q2	$247K	Sell	3,208 -127	-4%	-$9.67K	0.14%	132
2022 Q1	$244K	Sell	3,335 -1,281	-28%	-$86K	0.1%	156
2021 Q4	$288K	Buy	4,616 +764	+20%	+$44.8K	0.08%	109
2021 Q3	$228K	Buy	3,852 +486	+14%	+$32K	0.05%	165
2021 Q2	$225K	Buy	+3,366	New	+$219K	0.04%	175
2021 Q1	–	Sell	-1,201	Closed	-$74K	–	304
2020 Q4	$74K	Buy	+1,201	New	+$73.8K	0.01%	282